Bioadaptives (BDPT) Amortization of Deferred Charges (2021 - 2026)

Bioadaptives has disclosed Amortization of Deferred Charges across 5 years of filings, most recently posting $71879.0 for Q1 2026.

• Amortization of Deferred Charges for Q1 2026 came in at $71879.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $71879.0 (up 757.03% YoY), and the FY2025 annual result was $25132.0, down 52.21% from the prior year.
• Amortization of Deferred Charges came in at $71879.0 for Q1 2026 at Bioadaptives, up from $8387.0 in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $81674.0 in Q3 2022 to a low of $8387.0 in Q2 2024.
• The 4-year median for Amortization of Deferred Charges is $42152.0 (2023), against an average of $43928.4.
• Across the five-year window, Amortization of Deferred Charges soared 2217.35% in 2022 and plunged 87.84% in 2023, its largest moves.
• Bioadaptives' Amortization of Deferred Charges stood at $77965.0 in 2022, then sank by 65.07% to $27237.0 in 2023, then slumped by 69.21% to $8387.0 in 2024, then surged by 757.03% to $71879.0 in 2026.
• The last three Amortization of Deferred Charges figures came in at $71879.0 (Q1 2026), $8387.0 (Q2 2024), and $44205.0 (Q1 2024), per Business Quant data.